Nanjing Begin Period Cash Flow from 2010 to 2024

688273 Stock   25.66  0.54  2.15%   
Nanjing Medlander's Begin Period Cash Flow is increasing over the years with slightly volatile fluctuation. Overall, Begin Period Cash Flow is expected to go to about 1.2 B this year. Begin Period Cash Flow is the amount of cash Nanjing Medlander Medical has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
1.2 B
Current Value
1.2 B
Quarterly Volatility
385 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nanjing Medlander financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanjing Medlander's main balance sheet or income statement drivers, such as Tax Provision of 10.4 M, Net Interest Income of 15.1 M or Interest Income of 15.6 M, as well as many indicators such as . Nanjing financial statements analysis is a perfect complement when working with Nanjing Medlander Valuation or Volatility modules.
  
This module can also supplement various Nanjing Medlander Technical models . Check out the analysis of Nanjing Medlander Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Nanjing Stock

Nanjing Medlander financial ratios help investors to determine whether Nanjing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanjing with respect to the benefits of owning Nanjing Medlander security.